Norton Evan 4
4 · NeuroPace Inc · Filed Apr 26, 2021
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Norton Evan
Director
Transactions
- Conversion
Common Stock
2021-04-26+3,454,422→ 4,042,657 total(indirect: See Footnote) - Conversion
Series B' Preferred Stock
2021-04-26−3,454,422→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (3,454,422 underlying)
Footnotes (2)
- [F1]Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC.
- [F2]Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.